Quick Notes: M&A, Divestitures and Collaborations — Aug. 26, 2024

This edition of Quick Notes features announcements of Baxter’s agreement to sell its Vantive Kidney care segment, Merck’s B-Cell depletion therapy acquisition, Triastek collaboration with BioNTech and Crown Laboratories and Revance Merger.
Source: Drug Industry Daily